Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized ipratropium bromide for oxygenation and end-expiratory lung volume in mechanically ventilated children
NL-OMON32902Phase 2Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ipratropium bromide in Chest diseases, sponsored by University Medical Center Groningen. Started Dec 2009; status: active, not recruiting.
02
Drugs
ipratropium bromide
03
Conditions
Chest diseases
Beyond the preview
Go deeper on NL-OMON32902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32902.